PreveCeutical Medical Inc. has created a new division to develop and train an Artificial Intelligence tool that will be capable of learning R&D, clinical trials, and other clinical information. Shawn Sadler has been hired as Head of Artificial Intelligence. PreveCeutical has purchased the domain www.preveceutical.ai to provide information on the AI program and development.
PreveCeutical Medical Inc. has announced the creation of a new division to develop and train an Artificial Intelligence tool that will be capable of learning R&D, clinical trials, and other clinical information. PreveCeutical plans to use this tool in the development and process of all their clinical programs. This should enhance, accelerate, and predict outcomes, processes, and solutions, amongst other selected data. In preparation, the company has purchased the domain www.preveceutical.ai, which will be developed over the coming weeks to provide information on the AI program and development.
To lead this exciting new division, PreveCeutical has hired Mr. Shawn Sadler as Head of Artificial Intelligence, effective April 21, 2023. Shawn Sadler has over 25 years of experience in the information technology industry, delivering cutting-edge solutions that have helped businesses achieve significant growth and success. His expertise in network design and engineering, combined with his exceptional project management skills, make him an invaluable asset to PreveCeutical. He will align PreveCeutical business objectives with emerging AI solutions and serve as a Head of Artificial Intelligence.
Shawn Sadler will focus on developing the frameworks required for AI analytics of research data, preparing existing data for ingestion to their proprietary Large Language Model (LLM), working with research scientists to build tools to enhance their workflows, analyzing large data sets to identify unique patterns, leveraging predictive analytics to forecast future trends, identifying potential risks and opportunities, and making informed decisions based on data-driven insights. He will also optimize data collection and analysis processes to improve efficiency and accuracy, while also reducing costs and minimizing errors, and create data visualization that will help research scientists create interactive visualizations that can make complex data more accessible and understandable.
As a quantum computing evangelist, I am thrilled to see PreveCeutical taking the lead in AI technology. The use of AI in medical technologies will revolutionize the healthcare industry and lead to groundbreaking discoveries. With the hiring of Shawn Sadler as Head of Artificial Intelligence, I am confident that PreveCeutical will be at the forefront of AI technology and will continue to develop innovative products through clinical trials and commercialization. The launch of this new division for AI development is a significant step towards the future, and I am excited to see what PreveCeutical will achieve with the use of AI technology.